Literature DB >> 12748560

Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?

S Gronau1, D Koenig-Greger, M Jerg, H Riechelmann.   

Abstract

OBJECTIVE: Impaired detoxification of carcinogens found in tobacco smoke appears to increase the risk for tobacco associated cancer. The objective of this study was to investigate concomitant polymorphisms in genes encoding for various detoxification enzymes in patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: In 187 patients with HNSCC and in 139 healthy control subjects, the polymorphisms of cytochrome P450 1A1 (CYP1A1), cytochrome P450 2D6 (CYP2D6), and glutathione S-transferase mu1 and Theta (GSTM1, GSTT1) were detected by polymerase chain reaction.
RESULTS: No significant association were identified between CYP1A1 and CYP2D6 gene polymorphisms and HNSCC. Patients with laryngeal cancer revealed the GSTM1 null genotype more frequently than did the control subjects (P < 0.05). The coincidence of GSTM1 and GSTT1 null genotype was found twice as great in patients as in control subjects (P < 0.05).
CONCLUSIONS: It is assumed that detoxification enzymes are functionally redundant and only the simultaneous deficiency of several detoxification enzymes increase the risk for HNSCC in alcohol- and tobacco-exposed individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748560     DOI: 10.1016/S0194-59980300176-1

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  26 in total

1.  Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population.

Authors:  Tanima Ghosh; Shalini Gupta; Prachi Bajpai; Deepti Agarwal; Mohit Agarwal; O P Gupta; Deepa Agrawal
Journal:  Mol Biol Rep       Date:  2012-07-01       Impact factor: 2.316

2.  Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.

Authors:  Javed Hussain Choudhury; Seram Anil Singh; Sharbadeb Kundu; Biswadeep Choudhury; Fazlur R Talukdar; Shilpee Srivasta; Ruhina S Laskar; Bishal Dhar; Raima Das; Shaheen Laskar; Manish Kumar; Wetetsho Kapfo; Rosy Mondal; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2015-02-28

3.  Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses.

Authors:  Wen-Lei Zhuo; Yan Wang; Xian-Lu Zhuo; Bo Zhu; Yi Zhu; Zheng-Tang Chen
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-28       Impact factor: 4.553

4.  Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.

Authors:  Soya Sisy Sam; Vinod Thomas; K S Reddy; Gopalakrishnan Surianarayanan; Adithan Chandrasekaran
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-10       Impact factor: 4.553

5.  CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.

Authors:  Gustavo Jacob Lourenço; Erika Furquim Soledade Neves Silva; José Augusto Rinck-Junior; Carlos Takahiro Chone; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2011-08-26

6.  GSTM1 null polymorphisms is associated with laryngeal cancer risk: a meta-analysis.

Authors:  Yong Zhang; Wei Chen; Jun-feng Ji; Zhi-yi Wang; Ming-hai Wu; Kai Zhang; Qiu-ping Wang
Journal:  Tumour Biol       Date:  2014-03-19

7.  Quantitative assessment of the association between GSTM1 null genotype and laryngeal cancer risk.

Authors:  Hui Xiao; Minghua Li; Linli Tian; Bin Zha; Ming Liu; Hongchao Yao
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

8.  Polymorphisms of the CYP1A1 and CYP2E1 genes in head and neck squamous cell carcinoma risk.

Authors:  Nathália Moreno Cury; Anelise Russo; Ana Lívia Silva Galbiatti; Mariângela Torreglosa Ruiz; Luiz Sérgio Raposo; José Victor Maniglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2011-05-18       Impact factor: 2.316

9.  GSTM1 null genotype is a risk factor for laryngeal cancer.

Authors:  Xuejun Liu; Qijun Fan; Liyan Ni; Fanli Liu; Saiyu Huang; Jinjian Gao; Bobei Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes.

Authors:  Shama C Buch; Valle Nazar-Stewart; Joel L Weissfeld; Marjorie Romkes
Journal:  Head Neck       Date:  2008-09       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.